Product NDC: | 54092-252 |
Proprietary Name: | Fosrenol |
Non Proprietary Name: | lanthanum carbonate |
Active Ingredient(s): | 500 mg/1 & nbsp; lanthanum carbonate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, CHEWABLE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 54092-252 |
Labeler Name: | Shire US Manufacturing Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021468 |
Marketing Category: | NDA |
Start Marketing Date: | 20041026 |
Package NDC: | 54092-252-90 |
Package Description: | 2 BOTTLE in 1 PACKAGE (54092-252-90) > 45 TABLET, CHEWABLE in 1 BOTTLE (54092-252-45) |
NDC Code | 54092-252-90 |
Proprietary Name | Fosrenol |
Package Description | 2 BOTTLE in 1 PACKAGE (54092-252-90) > 45 TABLET, CHEWABLE in 1 BOTTLE (54092-252-45) |
Product NDC | 54092-252 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | lanthanum carbonate |
Dosage Form Name | TABLET, CHEWABLE |
Route Name | ORAL |
Start Marketing Date | 20041026 |
Marketing Category Name | NDA |
Labeler Name | Shire US Manufacturing Inc. |
Substance Name | LANTHANUM CARBONATE |
Strength Number | 500 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] |